Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.8mm RC, SLA? 12mm, Ti, Loxim: medical device reports filed with FDA

2,918 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,918
device reports naming the brand
0% of all MAUDE reports · about 427 a year
964
reports, 12 months to August 2026
754 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,918 medical device reports received by FDA name the brand "BLT ?4.8mm RC, SLA? 12mm, Ti, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

964 reports arrived in the 12 months to August 2026, up 28% from 754 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (87.1%), loss of osseointegration (9.8%) and difficult to insert (0.4%). The patient problems coded most often are fibrosis, pain and swelling/ edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

086172Sep 2021: 6Oct 2021: 10Nov 2021: 17Dec 2021: 152022Jan 2022: 19Feb 2022: 6Mar 2022: 7Apr 2022: 13May 2022: 14Jun 2022: 20Jul 2022: 24Aug 2022: 24Sep 2022: 20Oct 2022: 11Nov 2022: 24Dec 2022: 92023Jan 2023: 13Feb 2023: 15Mar 2023: 14Apr 2023: 29May 2023: 29Jun 2023: 28Jul 2023: 31Aug 2023: 57Sep 2023: 31Oct 2023: 23Nov 2023: 45Dec 2023: 492024Jan 2024: 43Feb 2024: 44Mar 2024: 27Apr 2024: 59May 2024: 51Jun 2024: 38Jul 2024: 58Aug 2024: 45Sep 2024: 63Oct 2024: 39Nov 2024: 58Dec 2024: 752025Jan 2025: 64Feb 2025: 40Mar 2025: 38Apr 2025: 43May 2025: 0Jun 2025: 172Jul 2025: 56Aug 2025: 106Sep 2025: 117Oct 2025: 69Nov 2025: 89Dec 2025: 872026Jan 2026: 74Feb 2026: 69Mar 2026: 60Apr 2026: 61May 2026: 68Jun 2026: 103Jul 2026: 68Aug 2026: 99

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04418812019: 5720192020: 7220202021: 15120212022: 19120222023: 36420232024: 60020242025: 88120252026: 6022026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,918
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report93.9%2,740
Voluntary report0%0
User facility report0%0
Distributor report6.1%178
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,54287.1%62.8%
Loss of osseointegration2859.8%22.4%
Difficult to insertthe device was hard to insert120.4%0.4%
Fracturea broken bone80.3%1.6%
Separation failure30.1%0.1%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis57619.7%
Painpain, site not specified45415.6%
Swelling/ edema1936.6%
Inflammationinflammation1695.8%
Hemorrhage/blood loss/bleeding752.6%
Tissue damage742.5%
Fistula321.1%
Abscessa collection of pus291%
Hypersensitivity/allergic reaction210.7%
Hyperresponsive to stimuli160.5%
Numbnessnumbness140.5%
Failure of implant70.2%
Swellingswelling60.2%
Inadequate osseointegration40.1%
Sinus perforation30.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.8mm RC, SLA? 12mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports2,9183,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer93.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.8mm RC, SLA? 12mm, Ti, Loxim reports

How many FDA reports name BLT ?4.8mm RC, SLA? 12mm, Ti, Loxim?

2,918 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 964 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (87.1%), loss of osseointegration (9.8%), difficult to insert (0.4%), fracture (0.3%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (93.9%) and distributor reports (6.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.8mm RC, SLA? 12mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.